The Effective Participation of a Clinical Pharmacist in Detecting Medication Errors in the COVID-19 Intensive Care Unit
With the emergence of the COVID-19 pandemic, a large number of patients required hospitalization and intensive care unit admissions. Patients with pre-existing medical conditions were associated with a higher chance of severe disease. On the other hand, medication errors in part resulting from polyp...
Saved in:
Main Authors: | Dena Firouzabadi (Author), Seyed Mohammad Hosseini Saadi (Author), Negar Firouzabadi (Author) |
---|---|
Format: | Book |
Published: |
Shiraz University of Medical Sciences,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of clinical pharmacist's interventions on potential drug-Drug interactions in the cardiac care units of two university hospitals in Shiraz, South of Iran
by: Mojtaba Shafiekhani, et al.
Published: (2019) -
The Impact of Clinical Pharmacist Interventions on Medication Errors Management in the Postoperative Cardiac Intensive Care Unit
by: Naser Safaie, et al.
Published: (2021) -
Utility of a clinical pharmacist in the pediatric intensive care unit to identify and prevent medication errors
by: Ramaning Loni, et al.
Published: (2020) -
Evolution of SARS-CoV-2; The Omicron Variant and its Considerations, A Mini Review
by: Dena Firouzabadi
Published: (2022) -
Descriptive Report of Microorganisms Detected in Cultures of COVID-19 Patients Developing Secondary Infection After Tocilizumab Use
by: Dena Firouzabadi, et al.
Published: (2024)